Noriko Usui

Jikei University School of Medicine — Japan

Medicine · Health Sciences

38h-index6.5kcitations318works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(76), Chronic Myeloid Leukemia Treatments(74), Chronic Lymphocytic Leukemia Research(66), Acute Lymphoblastic Leukemia research(64), Lymphoma Diagnosis and Treatment(35)

Publications317 total

A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia
International Journal of Hematology·2024· 6 citedOpen Access
A PATIENT WITH ACUTE MYELOID LEUKEMIA WHO BECAME HB ANTIGEN- AND HBV-POSITIVE SIX MONTHS AFTER PLATELET TRANSFUSION: A CASE REPORT
Japanese Journal of Transfusion and Cell Therapy·2024Open Access
Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
International Journal of Hematology·2023· 3 cited
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
International Journal of Hematology·2023· 3 cited
A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis
International Journal of Hematology·2022· 7 cited
A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia
International Journal of Hematology·2022· 2 cited
Correction to: Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
International Journal of Clinical Oncology·2022Open Access
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2
International Journal of Clinical Oncology·2022· 29 citedOpen Access
Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1
International Journal of Clinical Oncology·2022· 38 citedOpen Access
Decision Analysis for Unrelated Bone Marrow Transplantation or Immediate Cord Blood Transplantation for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission
Transplantation and Cellular Therapy·2021· 2 citedOpen Access
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma
International Journal of Clinical Oncology·2021· 18 citedOpen Access
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy
International Journal of Hematology·2021· 3 cited
Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia
Annals of Hematology·2020· 28 cited
Formation of the hyaline layer in sea-urchin eggs — As revealed by deformation induced by fixation with glutaraldehyde
2020
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature
Cancers·2020· 14 citedOpen Access
Three cases of CBT following Flu/Bu4/Mel conditioning for acute leukemia relapsed after allo-HSCT
日本造血細胞移植学会総会プログラム・抄録集·2020
Antimutagenic components in Spatholobus suberectus Dunn against N-methyl-N-nitrosourea
Genes and Environment·2019· 11 citedOpen Access
The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy
Blood·2019
[Acute lymphoblastic leukemia/ lymphoblastic lymphoma: ALL/LBL].
PubMed·2019
[Outcomes of primary central nervous system lymphoma patients treated with high-dose methotrexate and rituximab].
PubMed·2019· 1 cited
page 1 of 16Next →

Frequent Co-authors

Yasushi Miyazaki(20), Shigeki Ohtake(19), Tomoki Naoe(17), Yukio Kobayashi(13), Kazunori Ohnishi(13), Shuichi Miyawaki(12), Hitoshi Kiyoi(12), Yasunori Ueda(10), Norio Asou(10), Fumiharu Yagasaki(8), Toru Sakura(8), Kiyotoshi Imai(8), Itaru Matsumura(8), Hideki Akiyama(7), Keitaro Matsuo(7), Ryuzo Ohno(7), Koichi Miyamura(7), Chiaki Nakaseko(7), Akihiro Takeshita(7), T Naoe(7)